MicroRNA Monitoring in Human Alveolar Macrophages from Patients with Smoking-Related Lung Diseases: A Preliminary Study

Davida Mirra,Renata Esposito,Giuseppe Spaziano,Liberata Sportiello,Francesca Panico,Antonio Squillante,Maddalena Falciani,Ida Cerqua,Luca Gallelli,Erika Cione,Bruno D’Agostino
DOI: https://doi.org/10.3390/biomedicines12051050
IF: 4.757
2024-05-10
Biomedicines
Abstract:Chronic obstructive pulmonary disease (COPD) is a progressive lung disease that is commonly considered to be a potent driver of non-small cell lung cancer (NSCLC) development and related mortality. A growing body of evidence supports a role of the immune system, mainly played by alveolar macrophages (AMs), in key axes regulating the development of COPD or NSCLC phenotypes in response to harmful agents. MicroRNAs (miRNAs) are small non-coding RNAs that influence most biological processes and interfere with several regulatory pathways. The purpose of this study was to assess miRNA expression patterns in patients with COPD, NSCLC, and ever- or never-smoker controls to explore their involvement in smoking-related diseases. Bronchoalveolar lavage (BAL) specimens were collected from a prospective cohort of 43 sex-matched subjects to determine the expressions of hsa-miR-223-5p, 16-5p, 20a-5p, -17-5p, 34a-5p and 106a-5p by RT-PCR. In addition, a bioinformatic analysis of miRNA target genes linked to cancer was performed. Distinct and common miRNA expression levels were identified in each pathological group, suggesting their possible role as an index of NSCLC or COPD microenvironment. Moreover, we identified miRNA targets linked to carcinogenesis using in silico analysis. In conclusion, this study identified miRNA signatures in AMs, allowing us to understand the molecular mechanisms underlying smoking-related conditions and potentially providing new insights for diagnosis or pharmacological treatment.
biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the expression patterns of microRNAs (miRNAs) in smoking - related lung diseases (such as chronic obstructive pulmonary disease (COPD) and non - small - cell lung cancer (NSCLC)), in order to understand the roles of these miRNAs in the occurrence and development of diseases and evaluate their potential as biomarkers. Specifically, by analyzing the specific miRNA expression levels in human alveolar macrophages (AMs), the study aims to identify miRNA signatures associated with COPD or NSCLC, which may help to understand the molecular mechanisms of smoking - related diseases and thus provide new insights for diagnosis or drug treatment. ### Research Background - Chronic obstructive pulmonary disease (COPD) is a fatal disease, causing high mortality worldwide and imposing a heavy burden on the medical system. - COPD is considered an important factor in promoting the development of non - small - cell lung cancer (NSCLC) and related deaths. - The immune system, especially alveolar macrophages (AMs), plays a crucial role in the development of COPD or NSCLC. - miRNAs are a class of small non - coding RNAs that can affect most biological processes and interfere with multiple regulatory pathways. ### Research Objectives - To evaluate the miRNA expression patterns in patients with COPD, NSCLC and control individuals with different smoking histories. - To explore the roles of these miRNAs in smoking - related diseases, especially whether they can be used as potential biomarkers for disease diagnosis or treatment. ### Methods - Bronchoalveolar lavage fluid (BAL) samples from 43 gender - matched subjects were collected. - The expression levels of hsa - miR - 223 - 5p, 16 - 5p, 20a - 5p, 17 - 5p, 34a - 5p and 106a - 5p were determined by RT - PCR technology. - Bioinformatics analysis was carried out to identify miRNA target genes related to cancer. ### Results - There are significant miRNA expression differences among different pathological groups (COPD, NSCLC and control groups with different smoking histories). - For example, the expression level of hsa - miR - 223 - 5p is the lowest in NSCLC patients, while the expression of hsa - miR - 106a - 5p is up - regulated in all pathological groups. - Bioinformatics analysis has revealed miRNA target genes related to cancer occurrence, such as BCL2, CYCS, E2F2, MCL1 and MYC, etc. ### Conclusions - This study has identified the miRNA signatures of AMs in COPD and NSCLC, which is helpful for understanding the molecular mechanisms of smoking - related diseases. - These findings may provide new ideas for the early diagnosis and treatment of diseases.